Company Valuation: Profarma Distribuidora de Produtos Farmacêuticos S.A.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 747.9 723.4 450 747.9 795.7 1,119
Change - -3.28% -37.8% 66.21% 6.39% 40.68%
Enterprise Value (EV) 1 1,277 1,482 1,291 1,698 1,813 2,286
Change - 16.05% -12.88% 31.53% 6.77% 26.1%
P/E Ratio 14.3x 9.25x 5.56x 10.6x 6.95x 9.42x
PBR 0.71x 0.67x 0.38x 0.6x 0.61x 0.83x
PEG - 0.2x 1.62x -0.8x 0.1x 2.46x
Capitalization / Revenue 0.14x 0.11x 0.06x 0.09x 0.08x 0.1x
EV / Revenue 0.23x 0.23x 0.17x 0.2x 0.18x 0.2x
EV / EBITDA 8.52x 9.11x 4.54x 5.74x 5.3x 5.65x
EV / EBIT 9.95x 10.9x 5.09x 6.5x 6.05x 6.53x
EV / FCF -50.4x -136x -22.6x -101x 11.3x 34.7x
FCF Yield -1.98% -0.73% -4.42% -0.99% 8.82% 2.88%
Dividend per Share 2 - 0.2706 0.1733 0.3858 0.575 -
Rate of return - 4.59% 4.72% 6.32% 8.86% -
EPS 2 0.4268 0.6377 0.6596 0.574 0.934 0.9697
Distribution rate - 42.4% 26.3% 67.2% 61.6% -
Net sales 1 5,481 6,413 7,816 8,662 10,154 11,451
EBITDA 1 149.9 162.7 284.2 295.6 342.1 404.5
EBIT 1 128.3 136.3 253.8 261.1 299.7 350.1
Net income 1 52.33 78.19 80.87 70.4 114.6 118.9
Net Debt 1 528.9 758.4 840.9 950 1,017 1,167
Reference price 2 6.100 5.900 3.670 6.100 6.490 9.130
Nbr of stocks (in thousands) 122,611 122,611 122,611 122,611 122,611 122,611
Announcement Date 16/03/21 16/03/22 15/03/23 07/03/24 18/03/25 17/03/26
1BRL in Million2BRL
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 160M
18.55x0.23x13.18x0.42% 94.25B
28.83x0.23x14.48x0.92% 52.43B
41.38x2.93x27.2x1.5% 21.42B
10.09x0.2x5.06x3% 8.13B
12.97x1x8.02x2.6% 7.54B
5.91x0.1x2.73x5.08% 6.77B
9.7x1.79x5.73x3.37% 6.49B
24.17x1.17x14.37x2.99% 5.32B
10.86x0.12x4.33x4.04% 3.53B
Average 18.05x 0.86x 10.57x 2.66% 20.6B
Weighted average by Cap. 22.32x 0.60x 13.76x 1.22%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. PFRM3 Stock
  4. Valuation Profarma Distribuidora de Produtos Farmacêuticos S.A.
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!